Cirrhosis and liver failure: Expanding phenotype of acid sphingomyelinase-deficient niemann-pick disease in adulthood

JIMD Reports

Volumn 15, Issue , 2015, Pages 117-121

  Lidove, Olivier ^a   Sedel, Frédéric ^b   Charlotte, Frédéric ^b   Froissart, Roseline ^c   Vanier, Marie T ^c  

^a GROUPE HOSPITALIER DIACONESSES CROIX SAINT SIMON   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

Enzyme replacement therapy; Interstitial lung disease; Liver failure; Liver fibrosis; Oral anticoagulant therapy

Indexed keywords

EID: 84974841292     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2014_306     Document Type: Chapter

References (17)

1. Dewhurst N, Besley GT, Finlayson ND, Parker AC (1979) Sea blue histiocytosis in a patient with chronic non-neuropathic Niemann–Pick disease. J Clin Pathol 32:1121–1127
2. Hollak CE, de Sonnaville ES, Cassiman D et al (2012) Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients. Mol Genet Metab 107:526–533
3. Iaselli F, Rea G, Cappabianca S, Fabozzi G et al (2011) Adult-onset pulmonary involvement in Niemann–Pick disease type B. Monaldi Arch Chest Dis 75:235–240
4. Labrune P, Bedossa P, Huguet P et al (1991) Fatal liver failure in two children with Niemann–Pick disease type B. J Pediatr Gastroenterol Nutr 13:104–109
5. McGovern MM, Aron A, Brodie SE et al (2006) Natural history of type A Niemann–Pick disease: possible endpoints for therapeutic trials. Neurology 66:228–232
6. McGovern MM, Wasserstein MP, Giugliani R et al (2008) A prospective, cross-sectional survey study of the natural history of Niemann–Pick disease type B. Pediatrics 122:e341–e349
7. McGovern MM, Lippa N, Bagiella E et al (2013) Morbidity and mortality in type B Niemann–Pick disease. Genet Med 15:618–623
8. Moles A, Tarrats N, Fernandez-Checa JC, Mari M (2012) Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann–Pick disease. J Biol Chem 287:1178–1188
9. Pavlu-Pereira H, Asfaw B, Poupctova H et al (2005) Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis 28:203–227
10. Rodriguez-Lafrasse C, Vanier MT (1999) Sphingosylphosphorylcho-line in Niemann–Pick disease brain: accumulation in type A but not in type B. Neurochem Res 24:199–205
11. Schuchman EH (2007) The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann–Pick disease. J Inherit Metab Dis 30:654–663
12. Takahashi T, Akiyama K, Tomihara M et al (1997) Heterogeneity of liver disorder in type B Niemann–Pick disease. Hum Pathol 28:385–388
13. Tassoni JP Jr, Fawaz KA, Johnston DE (1991) Cirrhosis and portal hypertension in a patient with adult Niemann–Pick disease. Gastroenterology 100:567–569
14. Thurberg BL, Wasserstein MP, Schiano T et al (2012) Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B). Am J Surg Pathol 36:1234–1246
15. Vanier MT (2013) Niemann–Pick diseases. Handb Clin Neurol 113:1717–1721
16. Vanier MT, Revol A, Fichet M (1980) Sphingomyelinase activities of various human tissues in control subjects and in Niemann–Pick disease – development and evaluation of a microprocedure. Clin Chim Acta 106:257–267
17. Wasserstein MP, Desnick RJ, Schuchman EH et al (2004) The natural history of type B Niemann–Pick disease: results from a 10-year longitudinal study. Pediatrics 114:e672–e677